News | 13 November 2012
Equities research analysts at Cowen initiated coverage on shares of Puma Biotechnology (NASDAQ: PBYI) in a research note issued to investors on Tuesday. The firm set an ?outperform? rating on the stock. A number of other analysts have also recently ...
Click on the link to read the full article at Daily Political
(This link will open in a new window)